Human Genome Epidemiology Literature Finder
Records 1 - 28 (of 28 Records) |
Query Trace: Multiple Sclerosis and CCR5[original query] |
---|
Frequencies of the G-protein beta3 subunit C825T polymorphism and the delta 32 mutation of the chemokine receptor-5 in patients with multiple sclerosis. Neuroscience letters 2002 Sep 330 (3): 293-5. Haase Claus G, Schmidt Stephan, Faustmann Pedro |
Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E). Multiple sclerosis (Houndmills, Basingstoke, England) 2002 Aug 8 (4): 295-8. Schreiber K, Otura A B, Ryder L P, Madsen H O, Jørgensen O S, Svejgaard A, Sorensen P |
A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology 2003 Jul 61 (2): 238-40. Kantor Rami, Bakhanashvili Mary, Achiron An |
Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta neurologica Scandinavica 2003 Dec 108 (6): 396-400. Luomala M, Lehtimäki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara |
Association of CCR5 delta32 deletion with early death in multiple sclerosis. Genetics in medicine : official journal of the American College of Medical Genetics 0 6 (3): 126-31. Gade-Andavolu Radhika, Comings David E, MacMurray James, Rostamkhani Masoud, Cheng Li S-C, Tourtellotte Wallace W, Cone Lawrence |
Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Multiple sclerosis (Houndmills, Basingstoke, England) 2004 Apr 10 (2): 149-52. Silversides J A, Heggarty S V, McDonnell G V, Hawkins S A, Graham C |
Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis. Acta neurologica Scandinavica 2004 May 109 (5): 342-7. Pulkkinen K, Luomala M, Kuusisto H, Lehtimäki T, Saarela M, Jalonen TO, Elovaara I |
CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. Journal of neuroimmunology 2005 Dec 169 (1-2): 137-43. Kantarci Orhun H, Morales Yazmín, Ziemer Patricia A, Hebrink David D, Mahad Don J, Atkinson Elizabeth J, Achenbach Sara J, De Andrade Mariza, Mack Matthias, Ransohoff Richard M, Lassmann Hans, Bruck Wolfgang, Weinshenker Brian G, Lucchinetti Claudia |
Three allele combinations associated with multiple sclerosis. BMC medical genetics 2006 7 (): 63. Favorova Olga O, Favorov Alexander V, Boiko Alexey N, Andreewski Timofey V, Sudomoina Marina A, Alekseenkov Alexey D, Kulakova Olga G, Gusev Eugenyi I, Parmigiani Giovanni, Ochs Michael |
CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis. Journal of neuroimmunology 2007 Oct 190 (1-2): 157-64. van Veen Tineke, Nielsen Jessica, Berkhof Johannes, Barkhof Frederik, Kamphorst Wouter, Bö Lars, Ravid Rivka, Verweij Cor L, Huitinga Inge, Polman Chris H, Uitdehaag Bernard M |
Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2008 Jan 62 (1): 26-30. Guerini Franca R, Delbue Serena, Zanzottera Milena, Agliardi Cristina, Saresella Marina, Mancuso Roberta, Maserati Renato, Marchioni Enrico, Gori Andrea, Ferrante Pasqua |
Chemokine receptor CCR5 in interferon-treated multiple sclerosis. Acta neurologica Scandinavica 2007 Jun 115 (6): 413-8. Sellebjerg F, Kristiansen T B, Wittenhagen P, Garred P, Eugen-Olsen J, Frederiksen J L, Sørensen T |
Influence of CCR5-Delta32 genotype in Spanish population with multiple sclerosis. Neurogenetics 2007 Aug 8 (3): 201-5. Otaegui D, Ruíz-Martínez J, Olaskoaga J, Emparanza J I, López de Munain |
CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population. Cellular and molecular neurobiology 2009 Dec 29 (8): 1205-9. Shahbazi Majid, Ebadi Hamid, Fathi Davood, Roshandel Danial, Mahamadhoseeni Mana, Rashidbaghan Azam, Mahammadi Narges, Mahammadi Mahammad Reza, Zamani Mah |
[Genetic predisposition to multiple sclerosis as a polygenic autoimmune disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinsko? promyshlennosti Rossi?sko? Federatsii, Vserossi?skoe obshchestvo nevrologov [i] Vserossi?skoe obshchestvo psikhiatrov 2009 109 (7 Suppl 2): 16-22. Favorova O O, Favorov A V, Bo?ko A N, Sudomoina M A, Andreevski? T V, Alekseenkov A D, Kulakova O G, Gusev E I, Parmigiani G, Ochs M |
CCR5?32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients. Multiple sclerosis international 2011 2011 153282. D'Angelo Rosalia, Crisafulli Concetta, Rinaldi Carmela, Ruggeri Alessia, Amato Aldo, Sidoti Antoni |
Family Analysis of Linkage and Association of HLA-DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9 and TIMP1 Gene Polymorphisms with Multiple Sclerosis. Acta naturae 2012 6 3 (1): 85-92. Makarycheva O Yu, Tsareva E Yu, Sudomoina M A, Kulakova O G, Titov B V, Bykova O V, Gol'tsova N V, Kuzenkova L M, Boiko A N, Favorova O |
[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. Molekuliarnaia biologiia 0 45 (6): 963-72. Tsareva E Iu, Kulakova O G, Makarycheva O Iu, Bo?ko A N, Shchur S G, Lashch N Iu, Popova N F, Gusev E I, Bashinskaia V V, L'vov D V, Favorov A V, Ochs M F, Favorova O |
Allelic combinations of immune-response genes as possible composite markers of IFN-ß efficacy in multiple sclerosis patients. Pharmacogenomics 2012 Nov 13 (15): 1689-700. Kulakova Olga G, Tsareva Ekaterina Yu, Boyko Alexey N, Shchur Sergey G, Gusev Evgeny I, Lvovs Dmitrijs, Favorov Alexander V, Vandenbroeck Koen, Favorova Olga |
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors. Multiple sclerosis (Houndmills, Basingstoke, England) 2014 Apr 20 (5): 548-57. Thewissen Kristof, Nuyts Amber H, Deckx Nathalie, Van Wijmeersch Bart, Nagels Guy, D'hooghe Marie, Willekens Barbara, Cras Patrick, Eijnde Bert O, Goossens Herman, Van Tendeloo Viggo F I, Stinissen Piet, Berneman Zwi N, Hellings Niels, Cools Nathal |
The chemokine receptor CCR5 ?32 allele in natalizumab-treated multiple sclerosis. Acta neurologica Scandinavica 2014 Jan 129 (1): 27-31. Møller M, Søndergaard H B, Koch-Henriksen N, Sorensen P S, Sellebjerg F, Oturai A |
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility. Immunological investigations 2013 Dec . Song GG, Lee YH |
Comparative pharmacogenetics of multiple sclerosis: IFN-ß versus glatiramer acetate. Pharmacogenomics 2014 Apr 15 (5): 679-85. Kulakova Olga G, Tsareva Ekaterina Yu, Lvovs Dmitrijs, Favorov Alexander V, Boyko Alexey N, Favorova Olga |
Chemokine receptor V ?32 deletion in multiple sclerosis patients in Csongrád County in Hungary and the North-Bácska region in Serbia. Human immunology 2015 Jan 76 (1): 59-64. Török Nóra, Molnár Kinga, Füvesi Judit, Karácsony Mária, Zsiros Viktória, Fejes-Szabó Annamária, Fiatal Szilvia, Ádány Róza, Somogyvári Ferenc, Stojiljkovi? Olivera, Vécsei László, Bencsik Kriszti |
Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-ß therapy. IUBMB life 2016 Jun . Karam Rehab A, Rezk Noha A, Amer Mona M, Fathy Hala |
Chemokine gene variants in schizophrenia. Nordic journal of psychiatry 2016 Feb 1-6. Dasdemir Selcuk, Kucukali Cem Ismail, Bireller Elif Sinem, Tuzun Erdem, Cakmakoglu Bed |
CCR5?32 - A piece of protection in the inflammatory puzzle of multiple sclerosis susceptibility. Human immunology 2018 May . Troncoso Lian Lopes, Pontillo Alessandra, Oliveira Enedina Maria Lobato de, Finkelszteijn Alessandro, Schneider Silvete, Chies José Artur Bo |
Interleukin-10 Promoter and the CCR5 Polymorphisms in Iranian Azari Population with Multiple Sclerosis. Iranian journal of immunology : IJI 2021 Sep 18 (3): 211-215. Asgharzadeh Mohammad, Sanajoo Davood, Mahdavi Poor Behroz, Samadi Kafil Hossein, Gholizadeh Pourya, Rashedi Jal |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 20, 2024
- Content source: